Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ligand Pharm
(NQ:
LGND
)
80.06
-1.28 (-1.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
85,119
Open
81.04
Bid (Size)
75.00 (2)
Ask (Size)
85.00 (2)
Prev. Close
81.34
Today's Range
78.81 - 81.23
52wk Range
49.24 - 94.57
Shares Outstanding
16,676,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ligand to Participate in Upcoming Investor Conferences
May 23, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
3 Magnificent Growth Stocks to Buy Hand Over Fist
May 22, 2024
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
Performance
YTD
+10.72%
+10.72%
1 Month
-6.97%
-6.97%
3 Month
+10.98%
+10.98%
6 Month
+15.69%
+15.69%
1 Year
+3.58%
+3.58%
More News
Read More
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
May 20, 2024
Via
InvestorPlace
LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Ligand Reports First Quarter 2024 Financial Results
May 07, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Ligand Pharmaceuticals's Earnings: A Preview
February 26, 2024
Via
Benzinga
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 07, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Don't Overlook These Top Medical Stocks As Q1 Earnings Approach
May 07, 2024
Via
Talk Markets
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
April 23, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
7 Small-Cap Stocks for the Thinking Speculator
April 08, 2024
Via
InvestorPlace
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
April 08, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
April 03, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
March 05, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
February 27, 2024
Via
Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Via
Benzinga
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
February 27, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday Session
February 27, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via
Benzinga
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
February 22, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
February 16, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
February 13, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.